Drug Trial Radar · NCT02750293
The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors
Last checked: Nov 19, 2026Latest source record: Oct 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
411
Actual
Start
Jun 2015
Primary completion
Aug 2017
Study completion Sep 2017
Sponsor
- Lead sponsor
- University of TromsoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 25, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Six-hundred subjects with vitamin D deficiency will be randomized to vitamin D 3000 IU per day versus placebo for 4 months, with effects on cardiovascular risk factors as main endpoint
Conditions
- Vitamin D Deficiency
Interventions
CholecalciferolDrug
Vitamin D preparation
PlaceboDrug
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in systolic and diastolic blood pressureTime frame: 4 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospital of North Norway
Tromsø, Norway
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.